[1] Tatara AM, Shah SR, Demian N, et al.Reconstruction of large mandibular defects using autologous tissues generated from in vivo bioreactors[J]. Acta Biomater, 2016, 45: 72-84. [2] Luo D, Rong Q, Chen Q.Finite-element design and optimization of a three-dimensional tetrahedral porous titanium scaffold for the reconstruction of mandibular defects[J]. Med Eng Phys, 2017, 47: 176-183. [3] Schrag C, Chang YM, Tsai CY, et al.Complete rehabilitation of the mandible following segmental resection[J]. J Surg Oncol, 2006, 94(6): 538-545. [4] Viateau V, Guillemin G, Bousson V, et al.Long-bone critical-size defects treated with tissue-engineered grafts: a study on sheep[J]. J Orthop Res, 2007, 25(6): 741-749. [5] Ismail HD, Phedy P, Kholinne E, et al.Mesenchymal stem cell implantation in atrophic nonunion of the long bones: a translational study[J]. Bone Joint Res, 2016, 5(7): 287-293. [6] Gjerde C, Mustafa K, Hellem S, et al.Cell therapy induced regeneration of severely atrophied mandibular bone in a clinical trial[J]. Stem Cell Res Ther, 2018, 9(1): 213-227. [7] Ardjomandi N, Duttenhoefer F, Xavier S, et al.In vivo comparison of hard tissue regeneration with ovine mesenchymal stem cells processed with either the FICOLL method or the BMAC method[J]. J Craniomaxillofac Surg, 2015, 43(7): 1177-1183. [8] McCarrel T, Fortier L. Temporal growth factor release from platelet-rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression[J]. J Orthop Res, 2009, 27(8): 1033-1042. [9] Hernigou P, Guissou I, Homma Y, et al.Percutaneous injection of bone marrow mesenchymal stem cells for ankle non-unions decreases complications in patients with diabetes[J]. Int Orthop, 2015, 39(8): 1639-1643. [10] Goel A, Sangwan SS, Siwach RC, et al.Percutaneous bone marrow grafting for the treatment of tibial non-union[J]. Injury, 2005, 36(1): 203-206. [11] Akcay S, Kazimoglu C.Bone marrow aspirate concentrate and platelet-rich plasma enhanced bone healing in distraction osteogenesis of the tibia[J]. Clin Orthop Relat Res, 2014, 472(7): 2301-2302. [12] Connick P, Kolappan M, Crawley C, et al.Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study[J]. Lancet Neurol, 2012, 11(2): 150-156. [13] Okoturo E, Ogunbanjo OV, Arotiba GT.Spontaneous regeneration of the mandible: an institutional audit of regenerated bone and osteocompetent periosteum[J]. J Oral Maxillofac Surg, 2016, 74(8): 1660-1667. [14] Sun Z, Kennedy KS, Tee BC, et al.Establishing a critical-size mandibular defect model in growing pigs: characterization of spontaneous healing[J]. J Oral Maxillofac Surg, 2014,72(9): 1852-1868. [15] Wu Y, Chen L, Scott PG, et al.Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis[J]. Stem cells, 2007, 25(10): 2648-2659. [16] Nitzsche F, Müller C, Lukomska B, et al.Concise review: MSC adhesion cascade-insights into homing and transendothelial migration[J]. Stem Cells, 2017, 35(6): 1446-1460. [17] Ishihara A, Helbig HJ, Sanchez-Hodge RB, et al.Performance of a gravitational marrow separator, multidirectional bone marrow aspiration needle, and repeated bone marrow collections on the production of concentrated bone marrow and separation of mesenchymal stem cells in horses[J]. Am J Vet Res, 2013, 74(6): 854-863. [18] Sun Z, Tee BC, Kennedy KS, et al.Scaffold-based delivery of autologous mesenchymal stem cells for mandibular distraction osteogenesis: preliminary studies in a porcine model[J]. PLoS One, 2013, 8(9): e74672. [19] Sun Z, Tee BC.Molecular variations related to the regional differences in periosteal growth at the mandibular ramus[J]. Anat Rec (Hoboken), 2011, 294(1): 79-87. [20] Miyazaki K, Miyazaki KW, Yamanaka A, et al.Reward probability and timing uncertainty alter the effect of dorsal raphe serotonin neurons on patience[J]. Nat Commun, 2018, 9(1): 2048-2058. [21] Sch?fer R, DeBaun MR, Fleck E, et al. Quantitation of progenitor cell populations and growth factors after bone marrow aspirate concentration[J]. J Transl Med, 2019, 17(1): 115-123. [22] Cuomo AV, Virk M, Petrigliano F, et al.Mesenchymal stem cell concentration and bone repair: potential pitfalls from bench to bedside[J]. J Bone Joint Surg Am, 2009, 91(5): 1073-1083. [23] Dominici M, Le Blanc K, Mueller I, et al.Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement[J]. Cytotherapy, 2006, 8(4): 315-317. [24] Wang X, Zheng F, Liu O, et al.Epidermal growth factor can optimize a serum-free culture system for bone marrow stem cell proliferation in a miniature pig model[J]. In Vitro Cell Dev Biol Anim, 2013, 49(10): 815-825. [25] Brückner S, Tautenhahn HM, Winkler S, et al.A fat option for the pig: hepatocytic differentiated mesenchymal stem cells for translational research[J]. Exp Cell Res, 2014, 321(2): 267-275. [26] Loi F, Cordova LA, Pajarinen J, et al.Inflammation, fracture and bone repair[J]. Bone, 2016, 86: 119-130. [27] Bielby R, Jones E, McGonagle D. The role of mesenchymal stem cells in maintenance and repair of bone[J]. Injury, 2007, 38(Suppl 1): S26-S32. [28] Claes L, Recknagel S, Ignatius A.Fracture healing under healthy and inflammatory conditions[J]. Nat Rev Rheumatol, 2012, 8(3): 133-143. [29] Schindeler A, McDonald MM, Bokko P, et al. Bone remodeling during fracture repair: the cellular picture[J]. Semin Cell Dev Biol, 2008, 19(5): 459-466. [30] Marsell R, Einhorn TA.The biology of fracture healing[J]. Injury, 2011, 42(6): 551-555. [31] Amable PR, Teixeira MVT, Carias RBV, et al.Mesenchymal stromal cell proliferation, gene expression and protein production in human platelet-rich plasma-supplemented media[J]. PLoS One, 2014, 9(8): e104662. [32] Jin HJ, Bae YK, Kim M, et al.Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy[J]. Int J Mol Sci, 2013, 14(9): 17986-18001. [33] Blázquez-Prunera A, Díez JM, Gajardo R, et al.Human mesenchymal stem cells maintain their phenotype, multipotentiality, and genetic stability when cultured using a defined xeno-free human plasma fraction[J]. Stem cell Res Ther, 2017, 8(1): 103-113. [34] Ksiazek K.A comprehensive review on mesenchymal stem cell growth and senescence[J]. Rejuvenation Res, 2009, 12(2): 105-116. [35] Li Z, Wang W, Xu H, et al.Effects of altered CXCL12/CXCR4 axis on BMP2/Smad/Runx2/Osterix axis and osteogenic gene expressions during osteogenic differentiation of MSCs[J]. Am J Transl Res, 2017, 9(4): 1680-1693. [36] Fujisawa R, Tamura M.Acidic bone matrix proteins and their roles in calcification[J]. Front Biosci (Landmark Ed), 2012, 17: 1891-1903. [37] Komori T.Regulation of Osteoblast Differentiation by Runx2[C]//Choi Y. Osteoimmunology[M]. Boston, MA: Springer US, 2010: 43-49. [38] Agarwal S, Drake J, Qureshi AT, et al.Characterization of cells isolated from genetic and trauma-induced heterotopic ossification[J]. PLoS One, 2016, 11(8): e0156253. [39] Bayer EA, Fedorchak MV, Little SR.The Influence of platelet-derived growth factor and bone morphogenetic protein presentation on tubule organization by human umbilical vascular endothelial cells and human mesenchymal stem cells in coculture[J]. Tissue Eng Part A, 2016, 22(21-22): 1296-1304. [40] Pountos I, Georgouli T, Henshaw K, et al.Release of growth factors and the effect of age, sex, and severity of injury after long bone fracture: a preliminary report[J]. Acta Orthop, 2013, 84(1): 65-70. |